129 related articles for article (PubMed ID: 30318592)
1. What drives variation in spending for breast cancer patients within geographic regions?
Sinaiko AD; Chien AT; Hassett MJ; Kakani P; Rodin D; Meyers DJ; Fraile B; Rosenthal MB; Landrum MB
Health Serv Res; 2019 Feb; 54(1):97-105. PubMed ID: 30318592
[TBL] [Abstract][Full Text] [Related]
2. Greater Spending Associated with Improved Survival for Some Cancers in OCM-Defined Episodes.
Baumgardner J; Shahabi A; Linthicum M; Vine S; Zacker C; Lakdawalla D
J Manag Care Spec Pharm; 2018 Jun; 24(6):504-513. PubMed ID: 29799330
[TBL] [Abstract][Full Text] [Related]
3. Cost variation and savings opportunities in the Oncology Care Model.
Baumgardner J; Shahabi A; Zacker C; Lakdawalla D
Am J Manag Care; 2018 Dec; 24(12):618-623. PubMed ID: 30586495
[TBL] [Abstract][Full Text] [Related]
4. Physician and facility drivers of spending variation in locoregional prostate cancer.
Rodin D; Chien AT; Ellimoottil C; Nguyen PL; Kakani P; Mossanen M; Rosenthal M; Landrum MB; Sinaiko AD
Cancer; 2020 Apr; 126(8):1622-1631. PubMed ID: 31977081
[TBL] [Abstract][Full Text] [Related]
5. The Role of Patient Factors, Cancer Characteristics, and Treatment Patterns in the Cost of Care for Medicare Beneficiaries with Breast Cancer.
Xu X; Herrin J; Soulos PR; Saraf A; Roberts KB; Killelea BK; Wang SY; Long JB; Wang R; Ma X; Gross CP
Health Serv Res; 2016 Feb; 51(1):167-86. PubMed ID: 26119176
[TBL] [Abstract][Full Text] [Related]
6. The implications of regional variations in Medicare spending. Part 1: the content, quality, and accessibility of care.
Fisher ES; Wennberg DE; Stukel TA; Gottlieb DJ; Lucas FL; Pinder EL
Ann Intern Med; 2003 Feb; 138(4):273-87. PubMed ID: 12585825
[TBL] [Abstract][Full Text] [Related]
7. Spending for Advanced Cancer Diagnoses: Comparing Recurrent Versus De Novo Stage IV Disease.
Hassett MJ; Banegas M; Uno H; Weng S; Cronin AM; O'Keeffe Rosetti M; Carroll NM; Hornbrook MC; Ritzwoller DP
J Oncol Pract; 2019 Jul; 15(7):e616-e627. PubMed ID: 31107629
[TBL] [Abstract][Full Text] [Related]
8. Acute hospital care is the chief driver of regional spending variation in Medicare patients with advanced cancer.
Brooks GA; Li L; Uno H; Hassett MJ; Landon BE; Schrag D
Health Aff (Millwood); 2014 Oct; 33(10):1793-800. PubMed ID: 25288424
[TBL] [Abstract][Full Text] [Related]
9. Geographic Variation in Household and Catastrophic Health Spending in India: Assessing the Relative Importance of Villages, Districts, and States, 2011-2012.
Mohanty SK; Kim R; Khan PK; Subramanian SV
Milbank Q; 2018 Mar; 96(1):167-206. PubMed ID: 29504205
[TBL] [Abstract][Full Text] [Related]
10. Regions with higher Medicare Part D spending show better drug adherence, but not lower medicare costs for two diseases.
Stuart B; Shoemaker JS; Dai M; Davidoff AJ
Health Aff (Millwood); 2013 Jan; 32(1):120-6. PubMed ID: 23297279
[TBL] [Abstract][Full Text] [Related]
11. Variation in Physician Spending and Association With Patient Outcomes.
Tsugawa Y; Jha AK; Newhouse JP; Zaslavsky AM; Jena AB
JAMA Intern Med; 2017 May; 177(5):675-682. PubMed ID: 28288254
[TBL] [Abstract][Full Text] [Related]
12. Regional variation in spending and survival for older adults with advanced cancer.
Brooks GA; Li L; Sharma DB; Weeks JC; Hassett MJ; Yabroff KR; Schrag D
J Natl Cancer Inst; 2013 May; 105(9):634-42. PubMed ID: 23482657
[TBL] [Abstract][Full Text] [Related]
13. Association of Financial Integration Between Physicians and Hospitals With Commercial Health Care Prices.
Neprash HT; Chernew ME; Hicks AL; Gibson T; McWilliams JM
JAMA Intern Med; 2015 Dec; 175(12):1932-9. PubMed ID: 26501217
[TBL] [Abstract][Full Text] [Related]
14. Extent and sources of geographic variation in Medicare end-stage renal disease expenditures.
Hirth RA; Tedeschi PJ; Wheeler JR
Am J Kidney Dis; 2001 Oct; 38(4):824-31. PubMed ID: 11576886
[TBL] [Abstract][Full Text] [Related]
15. Estimating Costs of Care Attributable to Cancer: Does the Choice of Comparison Group Matter?
Chen AB; Li L; Cronin AM; Brooks GA; Kavanagh BD; Schrag D
Health Serv Res; 2018 Aug; 53 Suppl 1(Suppl Suppl 1):3227-3244. PubMed ID: 28858372
[TBL] [Abstract][Full Text] [Related]
16. Cancer care spending and use by site of provider-administered chemotherapy in Medicare.
Shooshtari A; Kalidindi Y; Jung J
Am J Manag Care; 2019 Jun; 25(6):296-300. PubMed ID: 31211557
[TBL] [Abstract][Full Text] [Related]
17. Medicare Spending for Breast, Prostate, Lung, and Colorectal Cancer Patients in the Year of Diagnosis and Year of Death.
Chen CT; Li L; Brooks G; Hassett M; Schrag D
Health Serv Res; 2018 Aug; 53(4):2118-2132. PubMed ID: 28748564
[TBL] [Abstract][Full Text] [Related]
18. Contribution of preventable acute care spending to total spending for high-cost Medicare patients.
Joynt KE; Gawande AA; Orav EJ; Jha AK
JAMA; 2013 Jun; 309(24):2572-8. PubMed ID: 23797716
[TBL] [Abstract][Full Text] [Related]
19. Share of Oncology Versus Nononcology Spending in Episodes Defined by the Centers for Medicare & Medicaid Services Oncology Care Model.
Baumgardner JR; Shahabi A; Linthicum MT; Zacker C; Lakdawalla DN
J Oncol Pract; 2018 Nov; 14(11):e699-e710. PubMed ID: 30423271
[TBL] [Abstract][Full Text] [Related]
20. Hospice Use, Hospitalization, and Medicare Spending at the End of Life.
Zuckerman RB; Stearns SC; Sheingold SH
J Gerontol B Psychol Sci Soc Sci; 2016 May; 71(3):569-80. PubMed ID: 26655645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
